Joel L Young

Summary

Publications

  1. ncbi request reprint Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder
    Joel Young
    Rochester Center for Behavioral Medicine, 441 South Livernois, Suite 205, Rochester Hills, MI 48307, USA
    Adolesc Med State Art Rev 19:216-28, vii. 2008
  2. pmc Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Greg W Mattingly
    St Charles Psychiatric Associates Midwest Research, 4801 Weldon Spring Pkwy, Suite 300, St Charles, MO, USA
    BMC Psychiatry 13:39. 2013
  3. doi request reprint Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study
    Joel L Young
    Wayne State University School of Medicine, Detroit, MI, USA
    Psychiatry Res 207:127-33. 2013
  4. doi request reprint Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder
    Joel L Young
    Wayne State University School of Medicine, Detroit, MI 48307, USA
    Postgrad Med 125:162-8. 2013
  5. doi request reprint Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial
    Joel L Young
    Rochester Center for Behavioral Medicine, Wayne State University School of Medicine, Detroit, MI 48307, USA
    Clin Neuropharmacol 34:51-60. 2011
  6. ncbi request reprint Treatment of adult ADHD and comorbid disorders
    Joel L Young
    Rochester Center for Behavioral Medicine, Rochester, Michigan, USA
    CNS Spectr 11:10-2. 2006
  7. ncbi request reprint Fibromylagia, chronic fatigue, and adult attention deficit hyperactivity disorder in the adult: a case study
    Joel L Young
    Rochester Center for Behavioral Medicine, Rochester Hills, MI
    Psychopharmacol Bull 40:118-26. 2007
  8. ncbi request reprint Attention-deficit/hyperactivity disorder in adolescent males
    Howard Schubiner
    Department of Internal Medicine, Providence Hospital HS, Southfield, Michigan 48075, USA
    Adolesc Med 14:663-76, vii-viii. 2003

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder
    Joel Young
    Rochester Center for Behavioral Medicine, 441 South Livernois, Suite 205, Rochester Hills, MI 48307, USA
    Adolesc Med State Art Rev 19:216-28, vii. 2008
    ....
  2. pmc Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Greg W Mattingly
    St Charles Psychiatric Associates Midwest Research, 4801 Weldon Spring Pkwy, Suite 300, St Charles, MO, USA
    BMC Psychiatry 13:39. 2013
    ..This study examined clinical response and symptomatic remission in analyses of 2 studies of lisdexamfetamine dimesylate (LDX) in adults with ADHD...
  3. doi request reprint Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study
    Joel L Young
    Wayne State University School of Medicine, Detroit, MI, USA
    Psychiatry Res 207:127-33. 2013
    ..The possibility that dopaminergic medications could play an important role addressing the symptoms of CFS is also discussed...
  4. doi request reprint Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder
    Joel L Young
    Wayne State University School of Medicine, Detroit, MI 48307, USA
    Postgrad Med 125:162-8. 2013
    ..These cases also suggest the need for additional research to determine the prevalence of ADHD in patients who present with fatigue, and, in those meeting criteria for ADHD, the responsiveness of fatigue to psychostimulant treatment...
  5. doi request reprint Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial
    Joel L Young
    Rochester Center for Behavioral Medicine, Wayne State University School of Medicine, Detroit, MI 48307, USA
    Clin Neuropharmacol 34:51-60. 2011
    ..Atomoxetine (ATX) once daily was compared with placebo (PBO) in adults with attention-deficit/hyperactivity disorder (ADHD) at 12 and 24 weeks...
  6. ncbi request reprint Treatment of adult ADHD and comorbid disorders
    Joel L Young
    Rochester Center for Behavioral Medicine, Rochester, Michigan, USA
    CNS Spectr 11:10-2. 2006
  7. ncbi request reprint Fibromylagia, chronic fatigue, and adult attention deficit hyperactivity disorder in the adult: a case study
    Joel L Young
    Rochester Center for Behavioral Medicine, Rochester Hills, MI
    Psychopharmacol Bull 40:118-26. 2007
    ..This model supposes that FMS and CFS are central processing problems rather than peripheral disorders of muscles and joints...
  8. ncbi request reprint Attention-deficit/hyperactivity disorder in adolescent males
    Howard Schubiner
    Department of Internal Medicine, Providence Hospital HS, Southfield, Michigan 48075, USA
    Adolesc Med 14:663-76, vii-viii. 2003